Carolyn Berg has over 25 years of experience in pharmaceutical sales, marketing and business development. She is currently Vice President, Business Development for Catalent’s inhaled drug delivery solutions where she is responsible for growing the Inhalation business in North America and Europe. Prior to Catalent, Carolyn has held various leadership roles within Cipla, Teva Respiratory and Merck, and owned her own consulting practice for pharmaceutical and healthcare clients. Carolyn holds a Bachelor of Journalism in Public Relations and a Bachelor of Arts in French from the University of Texas at Austin, and an MBA from the University of South Carolina.